AIIMS

New collaboration for affordable COVID-19 drug 2-DG

New Delhi: Indian Institute of Chemical Technology (IICT), Hyderabad, a constituent laboratory of Council of Scientific and Industrial Research (CSIR), New Delhi, and Nosch Labs entered into a non-exclusive agreement for the transfer of the process knowhow for the synthesis of anti-Covid-19 drug 2-DG (2-Deoxy -D -Glucose). 2-DG has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), New Delhi, a lab of the Defence Research and Development Organisation (DRDO), in collaboration with Hyderabad-based pharma company Dr Reddy’s Laboratories (DRL). Nosch Labs will commence manufacturing 2-DG drug after obtaining regulatory clearances from the Drugs Controller General of India…
Read More
Dr. Harsh Vardhan presides over the Commencement Ceremony of 1st batch at AIIMS, Guwahati

Dr. Harsh Vardhan presides over the Commencement Ceremony of 1st batch at AIIMS, Guwahati

“It took almost 50 years and Sh. Atal Bihari Vajpayee for the 2nd AIIMS to be born even as a concept” “AIIMS in various parts of India is to reduce the ‘gaps’ in affordable tertiary health care, the long-term vision is to generate wellnesses amongst the general population of India” “Striving to achieve the WHO target of doctor-patient ratio of ‘1 for every 1000’ by this year itself”; Dr. Harsh Vardhan Dr. Harsh Vardhan, Union Minister of Health and Family Welfare today through video-conference presided over the commencement of the first batch of MBBS students of AIIMS Guwahati in the…
Read More